Piedmont Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-31,390
| Closed | -$8.9M | – | 634 |
|
|
2020
Q1 | $8.9M | Buy |
31,390
+3,534
| +13% | +$1M | 0.35% | 65 |
|
|
2019
Q4 | $9.05M | Buy |
27,856
+1,579
| +6% | +$513K | 0.31% | 81 |
|
|
2019
Q3 | $7.65M | Buy |
26,277
+410
| +2% | +$119K | 0.3% | 86 |
|
|
2019
Q2 | $7.6M | Buy |
25,867
+17,636
| +214% | +$5.18M | 0.3% | 85 |
|
|
2019
Q1 | $2.25M | Buy |
8,231
+535
| +7% | +$146K | 0.09% | 201 |
|
|
2018
Q4 | $1.72M | Buy |
7,696
+1,807
| +31% | +$404K | 0.08% | 207 |
|
|
2018
Q3 | $1.44M | Sell |
5,889
-11,541
| -66% | -$2.82M | 0.06% | 245 |
|
|
2018
Q2 | $3.61M | Sell |
17,430
-42,524
| -71% | -$8.81M | 0.17% | 129 |
|
|
2018
Q1 | $12.4M | Sell |
59,954
-25,835
| -30% | -$5.33M | 0.33% | 76 |
|
|
2017
Q4 | $16.3M | Sell |
85,789
-281
| -0.3% | -$53.4K | 0.33% | 78 |
|
|
2017
Q3 | $16.3M | Buy |
86,070
+2,663
| +3% | +$504K | 0.35% | 72 |
|
|
2017
Q2 | $14.6M | Buy |
83,407
+122
| +0.1% | +$21.3K | 0.32% | 81 |
|
|
2017
Q1 | $12.8M | Buy |
83,285
+707
| +0.9% | +$109K | 0.26% | 104 |
|
|
2016
Q4 | $11.7M | Buy |
82,578
+1,785
| +2% | +$252K | 0.24% | 115 |
|
|
2016
Q3 | $12.9M | Sell |
80,793
-8,350
| -9% | -$1.33M | 0.28% | 96 |
|
|
2016
Q2 | $13.2M | Sell |
89,143
-123
| -0.1% | -$18.2K | 0.27% | 94 |
|
|
2016
Q1 | $12.6M | Buy |
89,266
+1,371
| +2% | +$194K | 0.27% | 98 |
|
|
2015
Q4 | $12.5M | Buy |
87,895
+778
| +0.9% | +$110K | 0.26% | 101 |
|
|
2015
Q3 | $10.7M | Buy |
87,117
+697
| +0.8% | +$85.2K | 0.24% | 110 |
|
|
2015
Q2 | $11.2M | Buy |
+86,420
| New | +$11.2M | 0.24% | 117 |
|